Vaccines Europe

EU Member States are preparing to present their medium-term fiscal structural plans for the next 4-7 years to the European Commission by 20th September, and there is a critical window of opportunity to prioritise investment in health prevention, including immunisation. This new report by The European House-Ambrosetti, supported by IFPMA and Vaccines Europe, calls for a shift towards prevention-based healthcare to secure economic stability for EU health systems. The economic value of prevention has been well documented. For example, adult immunisation programmes return up to 19 times their initial investment. Despite this, most Member States dedicate only 0.5% of their healthcare budgets to prevention. We need an urgent change in direction - embedding preventative healthcare such as immunisation into EU Member States’ fiscal policies is paramount to ensure the economic sustainability of healthcare, social care, and welfare systems. https://bit.ly/4gpqWVw

Infectious diseases are a key element of many issues Europe is facing, from the ageing of the population to #AMR and climate change. Preventing the preventable can play a major role in enhancing the sustainability and resilience of healthcare systems, society and the economy - through investment in immunisation across the life course. Read more in our latest newsletter ➡ https://bit.ly/47UZ9Zd

With over 300 partnerships, the #COVID19 pandemic showcased the power of collaboration. A resilient vaccine supply chain relies on all stakeholders within the vaccine ecosystem working together to ensure people can get the vaccines they need, when they need them https://bit.ly/47viT5i #WeWontRest

The next edition of our quarterly newsletter is now live 📩 Dive in to learn more about prevention-based healthcare, resilient vaccine supply chains, #HTA for vaccines and more ➡ https://bit.ly/47UZ9Zd

Join us at The World Vaccine Congress Europe at the end of October where we will discuss vaccine innovation and how immunisation can help tackle #AMR, among other topics. Learn more: https://bit.ly/3MBQGAa

Have you read our first Consensus report? 📘 Dive into the MBVE Consensus report, which delivers concrete recommendations aimed at strengthening vaccination policies and programmes across Europe. 🔍 What’s inside?  👉 Our report is structured into four thematic chapters, each addressing a critical aspect of vaccination: 1️ Data and evidence for decision-making 2️ Beliefs, perceptions, and vaccine confidence 3️ Citizens’ access to vaccines 4️ Convergence and alignment across Europe 🔬 Each chapter was developed by a working group (WG), under the leadership of an expert in their respective field. 🤝 Alongside the chapters, the report highlights key cross-cutting themes that emphasise a holistic approach to immunisation: -              A life course approach to immunisation -              Intersectoral collaboration -              Strengthened and sustainable financing of immunisation systems -              Immunisation system performance monitoring and assessment 👉 Find the report on our website here https://lnkd.in/ehVPf-px 📢 Stay tuned as we dive deep into each chapter of the report & explore how these recommendations have the potential shape the future of immunisation!

As Europe’s demographics evolve, an #EUImmunisationStrategy is crucial for ensuring a healthy future for all generations. As reflected in the mission letter to the Commissioner-designate for Health and Animal Welfare, a comprehensive approach to health promotion and disease prevention throughout the life course is paramount. Let's invest in our health and build a stronger, more resilient Europe. Learn more: https://bit.ly/46qWUvd

Since the adoption of the Council Recommendation on Seasonal Influenza Vaccination in 2009, Europe has not only seen limited progress on #flu vaccination, but also gone through a pandemic caused by another respiratory virus, #COVID19, as well as a surge in the public health burden of #RSV. Now, 15 years after its adoption, and as we begin a new institutional mandate in the European Parliament and Commission, it is timely to reflect on how the 2009 Council Recommendation should be updated to reflect this new landscape. The 2024 edition of #EUFluDay will bring together policymakers, academics, health professionals, and industry leaders, to discuss the importance of data surveillance and digitalisation in achieving 75% vaccination uptake for flu as well as for RSV and COVID-19. ✅ Register now: https://bit.ly/3zC36oR

Manufacturing and packaging complexities, challenges in understanding demand and a number of external factors can cause delays in vaccine supply. We need to strengthen the supply chain to ensure people get the vaccines they need https://bit.ly/47viT5i #WeWontRest Kajsa Hagspiel

For people with underlying or chronic health conditions -such as those related to #CVD- vaccination against seasonal flu is even more important. Let’s be 100% committed to helping at-risk patients get vaccinated – and get protected. #TogetherAgainstFlu #WorldHeartDay #UseHeart